Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Cohn

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Seminars in Respiratory Infections|December 18, 2003
Treatment of latent tuberculosis infectionDavid L Cohn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Subclinical tuberculosis in HIV-infected patients: another challenge for the diagnosis of tuberculosis in high-burden countries?David L Cohn
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Tuberculosis and HIV coinfectionJacob M Gray, David L Cohn
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 27, 2010
Hepatic non-Hodgkin's lymphoma with lactic acidosis in HIV-infected patients: report of 2 casesMary H Kestler, Edward M Gardner, David L Cohn
Chest|March 12, 2003
Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infectionKenneth G Castro, John A Jereb, Venkatarama Rao Koppaka, et al.
American Journal of Clinical Pathology|June 24, 2003
Infectious diseases detected at autopsy at an urban public hospital, 1996-2001Lian A Bonds, Loretta Gaido, Jan E Woods, et al.
Sexually Transmitted Diseases|August 15, 2003
HIV transmission risk behavior and its relation to antiretroviral treatment adherenceRachel C Flaks, William J Burman, Patrick J Gourley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?Fred M Gordin, David L Cohn, John P Matts, et al.
Sexually Transmitted Diseases|March 21, 2006
Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care SettingsTimothy C Jenkins, Edward M Gardner, Mark W Thrun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microLJonathan E Kaplan, Debra L Hanson, David L Cohn, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Seminars in Respiratory Infections|December 18, 2003
Treatment of latent tuberculosis infectionDavid L Cohn
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 22, 2005
Subclinical tuberculosis in HIV-infected patients: another challenge for the diagnosis of tuberculosis in high-burden countries?David L Cohn
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Tuberculosis and HIV coinfectionJacob M Gray, David L Cohn
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|August 27, 2010
Hepatic non-Hodgkin's lymphoma with lactic acidosis in HIV-infected patients: report of 2 casesMary H Kestler, Edward M Gardner, David L Cohn
Chest|March 12, 2003
Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infectionKenneth G Castro, John A Jereb, Venkatarama Rao Koppaka, et al.
American Journal of Clinical Pathology|June 24, 2003
Infectious diseases detected at autopsy at an urban public hospital, 1996-2001Lian A Bonds, Loretta Gaido, Jan E Woods, et al.
Sexually Transmitted Diseases|August 15, 2003
HIV transmission risk behavior and its relation to antiretroviral treatment adherenceRachel C Flaks, William J Burman, Patrick J Gourley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 10, 2004
Hepatotoxicity of rifampin and pyrazinamide in the treatment of latent tuberculosis infection in HIV-infected persons: is it different than in HIV-uninfected persons?Fred M Gordin, David L Cohn, John P Matts, et al.
Sexually Transmitted Diseases|March 21, 2006
Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care SettingsTimothy C Jenkins, Edward M Gardner, Mark W Thrun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 18, 2003
When to begin highly active antiretroviral therapy? Evidence supporting initiation of therapy at CD4+ lymphocyte counts <350 cells/microLJonathan E Kaplan, Debra L Hanson, David L Cohn, et al.
Pageof 2